Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Qlonilik (clonidine hydrochloride)FDA approves Qlonilik (clonidine hydrochloride)29 July 2026The FDA approved Qlonilik (clonidine hydrochloride), a drug from Cmp Dev Llc. Form: Solution, Oral. Application NDA221094.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)